JODI CROSS: Open Payments
NPI 1881230712 · JAMESTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 31 payments from 9 companies in 2025. Trend: 2023 $242 · 2024 $318 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $283 |
| Antares Pharma, Inc. | 1 | $98 |
| ABBVIE INC. | 3 | $88 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Exact Sciences Corporation | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: CAPLYTA, XYOSTED, VRAYLAR, FARXIGA, The Cologuard Plus Collection Kit, XIFAXAN, Kerendia, Ozempic.
Industry payments across TN — which companies pay providers there.
